{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:24Z","timestamp":1755216744357,"version":"3.43.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>A standard treatment for disseminated intravascular coagulation in neonates has not yet been established. We analyzed the outcomes of 23 neonates who developed disseminated intravascular coagulation due to infection or asphyxia between 2004 and 2017. The overall survival rate was 95.7% on day 28 after anticoagulant therapy. In contrast, the bleeding-free survival rate was 69.6% (95% confidence interval, 53.1%-91.2%). Of the 6 neonates with intracranial bleeding, 2 developed neurological sequelae. The current study showed that intracranial bleeding remained a major problem in the early 2000s, despite the introduction of a new anticoagulant drug, recombinant thrombomodulin, at our institution since 2009.<\/jats:p>","DOI":"10.1097\/mph.0000000000002441","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T13:06:53Z","timestamp":1646226413000},"page":"e807-e811","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Intracranial Bleeding as a Major Problem Among Neonates With Disseminated Intravascular Coagulation After the Introduction of Recombinant Thrombomodulin"],"prefix":"10.1097","volume":"44","author":[{"given":"Yosuke","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Fuwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2141.2002.03674.x","article-title":"The investigation and management of neonatal haemostasis and thrombosis","volume":"119","author":"Williams","year":"2002","journal-title":"Br J Haematol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.thromres.2014.07.033","article-title":"Addition of recommendations for the use of recombinant human thrombomodulin to the \u201cExpert consensus for the treatment of disseminated intravascular coagulation in Japan","volume":"134","author":"Wada","year":"2014","journal-title":"Thromb Res"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-2007-996041","article-title":"Diagnosis of DIC in very low birth weight infants","volume":"24","author":"Shirahata","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"R5-20250804","first-page":"277","article-title":"Diagnosis of DIC in newborn infants","volume":"49","author":"Shirahata","year":"1983","journal-title":"Bibl Haematol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"F40","DOI":"10.1136\/fn.81.1.F40","article-title":"Outcome following pulmonary haemorrhage in very low birthweight neonates treated with surfactant","volume":"81","author":"Pandit","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/peds.2013-0372","article-title":"New South Wales and Australian Capital Territory Neonatal Intensive Care Units\u2019 Data Collection. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants","volume":"133","author":"Bolisetty","year":"2014","journal-title":"Pediatrics"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2015.03.029","article-title":"Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy","volume":"136","author":"Takezako","year":"2015","journal-title":"Thromb Res"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/SHK.0000000000001148","article-title":"Recombinant human-soluble thrombomodulin contributes to reduced mortality in sepsis patients with severe respiratory failure: a retrospective observational study using a multicenter dataset","volume":"51","author":"Yoshihiro","year":"2019","journal-title":"Shock"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"e012850","DOI":"10.1136\/bmjopen-2016-012850","article-title":"Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial","volume":"6","author":"Hagiwara","year":"2016","journal-title":"BMJ Open"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET Randomized Clinical Trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00431-013-2155-8","article-title":"Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation","volume":"173","author":"Shirahata","year":"2014","journal-title":"Eur J Pediatr"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcrc.2016.06.008","article-title":"The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation","volume":"36","author":"Yasuda","year":"2016","journal-title":"J Crit Care"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13613-017-0332-z","article-title":"Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation","volume":"7","author":"Iba","year":"2017","journal-title":"Ann Intensive Care"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/j.thromres.2012.10.004","article-title":"Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: a single institution experience","volume":"130","author":"Yagasaki","year":"2012","journal-title":"Thromb Res"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/PCC.0b013e3181c59032","article-title":"Study of protein C, protein S, and antithrombin III in newborns with sepsis","volume":"11","author":"El Beshlawy","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(07)60411-5","article-title":"Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial","volume":"369","author":"Nadel","year":"2007","journal-title":"Lancet"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00134-016-4225-7","article-title":"Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis","volume":"42","author":"Allingstrup","year":"2016","journal-title":"Intensive Care Med"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.thromres.2013.12.033","article-title":"Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation\u2014safety and efficacy in 1,032 patients with hematologic malignancy","volume":"133","author":"Asakura","year":"2014","journal-title":"Thromb Res"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","article-title":"Development of the human coagulation system in the full-term infant","volume":"70","author":"Andrew","year":"1987","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:13:40Z","timestamp":1754338420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002441","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"assertion":[{"value":"2021-07-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}